#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cushing's syndrome Chondrosarcoma Castleman's disease Hereditary spastic paraplegia Polycythaemia vera Haemophilia A with anti factor VIII Crigler-Najjar syndrome Mantle cell lymphoma Vulval cancer recurrent Systemic lupus erythematosus Transferrin decreased Oesophageal squamous cell carcinoma stage III PIK3CA-activated mutation Hepatic angiosarcoma Follicle centre lymphoma follicular grade I II – III refractory More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Diagnostics Mucopolysaccharidosis III – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Basic Information Niemann-Pick disease – Trials in Disease Kearns-Sayre syndrome Glycogen storage disease type II – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Congenital generalised lipodystrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BUDOPRUTUG Orlistat METHYLPHENIDATE Acetic Acid, Glacial TETANUS TOXOID Avibactam Abc-24F-116 Pal1-15 Acetate L-Threonine REGN7999 Oxygen Ph.eur. Nimodipine Hyoscine Butylbromide Zofenopril Calcium Pbf-999 Nizaracianine Triflutate Adg126 Copanlisib Dihydrochloride Insulin Human Ketamine More therapies…

    Learn about Your Condition

    Optic ischaemic neuropathy Colorectal cancer Cardiac failure chronic Urticaria Infertility male Pancreatic carcinoma recurrent Diminished ovarian reserve Soft tissue sarcoma Catatonia Leukaemia Graves' disease Sickle cell anaemia Tertiary adrenal insufficiency Muscle hypertrophy Vulvovaginal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Alteplase
    • Aflibercept
    Germany Ireland The Netherlands Poland Spain

  • Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valganciclovir
    • Letermovir
    France

  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Regadenoson
    • Syn2
    • Adenosine
    Finland Germany Italy The Netherlands Poland

  • Study on Ureter Imaging with Nizaracianine Triflutate for Patients 18+ Undergoing Abdominopelvic Surgery

    Recruiting

    4 1 1
    Investigated Drugs:
    • Nizaracianine Triflutate
    • Glucose Monohydrate
    The Netherlands

  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Ptg-Carcik-Cd19
    Italy
Previous Page
1 … 552 553 554 555 556 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!